In addition, tumor-derived exosomes can activate differentiation of CD14+ monocytes into CD14+ HLA-DR-/low cells, which suppress the differentiation and cell lysis ability of T cells (Valenti et al., 2006). The gene discussed is CD14; the disease is neoplasm.